Liquid Biopsy Predicts Resistance to Neoadjuvant Therapy in Esophageal Cancer Liquid Biopsy Predicts Resistance to Neoadjuvant Therapy in Esophageal Cancer
Researchers have developed and validated a liquid biopsy assay that can predict response to neoadjuvant therapy in patients with esophageal squamous-cell carcinoma, which may lead to more personalized treatment decisions.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 18, 2022 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Non-endoscopic Method to Detect Esophageal Cancer Promising Non-endoscopic Method to Detect Esophageal Cancer Promising
Esophageal squamous-cell carcinoma can be detected by analyzing a panel of methylated DNA biomarkers in cytologic samples obtained via a swallowable sponge-capsule device, researchers have found.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 5, 2022 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

What is in the Differential Diagnosis for Red, Orange or Yellow Skin Conditions?
Discussion This is the first in a short case series of differential diagnoses of colored skin conditions. A differential diagnosis by distribution and common pattern can be found here. For green, blue and violet conditions, a review can be found here. For black and white conditions, a review can be found here. For brown and grey conditions, a review can be found here. Note that any color can be a normal variant for an individual or is physiologic for a given state. The skin is the largest organ of the body. It can be easily examined but for many clinicians continues to be difficult to describe what they are seeing. Analo...
Source: PediatricEducation.org - April 25, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Dracen Pharmaceuticals announces two presentations at the American...
Data support that sirpiglenastat (DRP-104) has therapeutic potential in targeting KEAP1-mutant lung cancer as well as squamous cell carcinoma of the head and neck(PRWeb April 08, 2022)Read the full story at https://www.prweb.com/releases/2022/4/prweb18601225.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 8, 2022 Category: Pharmaceuticals Source Type: news

Mixed Message for Ultrasound in High-Risk Cutaneous Head and Neck Cancer
(MedPage Today) -- Ultrasound outperformed baseline clinical assessment for detection of lymph node metastasis in patients with high-risk cutaneous squamous cell carcinoma (SCC) of the head and neck, a retrospective Dutch study showed. Imaging... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 18, 2022 Category: Dermatology Source Type: news

Management of Cutaneous SCC of the Scalp With Brain Exposure Management of Cutaneous SCC of the Scalp With Brain Exposure
This case of advanced squamous cell carcinoma of the scalp with exposure of the brain was managed with a palliative approach.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 16, 2022 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

Can Liquid Biopsy Predict Oropharyngeal Cancer Recurrence? Can Liquid Biopsy Predict Oropharyngeal Cancer Recurrence?
Performing a routine liquid biopsy test for HPV DNA may allow recurrence of oropharyngeal squamous cell carcinoma to be identified before clinical signs develop, a new study suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 2, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Mayo Clinic Q & amp;A podcast: Recognizing skin cancer and reducing your risk
Skin cancer — the abnormal growth of skin cells — most often develops on skin exposed to the sun, but it also can occur on areas of skin not ordinarily exposed to sunlight. Skin cancer is the most common form of cancer in the U.S. "And the incidence of skin cancer is rising," says Dr. Dawn Davis, a Mayo Cli nic dermatologist. The three major types of skin cancer are basal cell carcinoma, squamous cell carcinoma… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 24, 2022 Category: Databases & Libraries Source Type: news

Nivolumab Combo Treats Advanced Esophageal Squamous - Cell Carcinoma
Overall survival longer in patients receiving first - line treatment with nivolumab plus chemo or nivolumab plus ipilimumab versus chemo alone (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 3, 2022 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Journal, Source Type: news

Nivolumab Combo Treats Advanced Esophageal Squamous-Cell Carcinoma
THURSDAY, Feb. 3, 2022 -- For patients with previously untreated, advanced esophageal squamous cell carcinoma, treatment with nivolumab plus chemotherapy or nivolumab plus ipilimumab results in significantly longer overall survival than chemotherapy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 3, 2022 Category: Pharmaceuticals Source Type: news

Metastases Occur in About 2 Percent of Cutaneous SCCs
TUESDAY, Feb. 1, 2022 -- Metastases develop in about 2 percent of cutaneous squamous cell carcinomas (cSCCs), according to a study published in the February issue of the Journal of the American Academy of Dermatology. Selin Tokez, from the Erasmus... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 1, 2022 Category: Pharmaceuticals Source Type: news

What Is the Survival Rate of Squamous Cell Carcinoma of the Skin?
Title: What Is the Survival Rate of Squamous Cell Carcinoma of the Skin?Category: Diseases and ConditionsCreated: 1/19/2022 12:00:00 AMLast Editorial Review: 1/19/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 19, 2022 Category: Cancer & Oncology Source Type: news

Mystery of the environmental triggers for cancer deepens
Study shows that our knowledge of why tumours form is still inadequateScientists will have to rethink howenvironmental triggers allow tumours to form and develop, one of Britain ’s leading cancer experts warned last week. Michael Stratton, director of the Wellcome Sanger Institute, said recent results from an international cancer research study – which aimed to pinpoint environmental triggers involved in oeosophageal cancer – indicated current scientific understanding of tumour formation was inadequate.The research – on a type known as oesophageal squamous cell carcinoma – was aimed at uncovering why certain part...
Source: Guardian Unlimited Science - October 24, 2021 Category: Science Authors: Robin McKie Tags: Cancer research Medical research UK news Science Source Type: news

New Opdivo/Yervoy Mesothelioma Clinical Trial Begins Soon
A novel clinical trial involving the immunotherapy combination of Opdivo and Yervoy will open soon in Chicago. The goal is to study the drugs’ efficacy when added to surgery for patients with peritoneal mesothelioma cancer. The single-center, phase II clinical trial follows a recent report detailing the impressive three-year effectiveness of the drug combination when used for unresectable pleural mesothelioma. Bristol Myers Squibb manufactures Opdivo and Yervoy, known generically as nivolumab and ipilimumab. The U.S. Food and Drug Administration approved the combination for pleural mesothelioma in 2020, making it t...
Source: Asbestos and Mesothelioma News - October 7, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

A Clinical and Biological Review of Keratoacanthoma A Clinical and Biological Review of Keratoacanthoma
Can keratoacanthomas be differentiated from cutaneous squamous cell carcinoma? This review compares the pathophysiology and clinical characteristics of the two, suggesting they are distinct entities.The British Journal of Dermatology (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 29, 2021 Category: Surgery Tags: Dermatology Journal Article Source Type: news